Publisher： Karger
E-ISSN： 2296-5262|39|3|118-121
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.39, Iss.3, 2016-02, pp. : 118-121
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeted Therapy in HER2-Positive Breast Cancer
Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. :
Access to resources
Recommend
Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. :
Neoadjuvant Therapy for HER2-positive Breast Cancer
Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. :
Targeted Therapy of Breast Cancer
Oncology Research and Treatment, Vol. 39, Iss. 3, 2016-02 ,pp. :
Trastuzumab as Single Agent Therapy for HER2-Positive Metastatic Breast Cancer
Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. :